Ensuring Access to Lower-Cost Medicines for Seniors Act of 2023
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Ensuring Access to Lower-Cost Medicines for Seniors Act of 2023 is a House bill introduced in the 118th Congress aimed at improving the affordability of prescription medications for senior citizens. While the official summary and full text of the bill are not available, the title and policy area indicate the bill focuses on health-related measures to reduce medication costs for seniors. The latest legislative action was referral to the Subcommittee on Health on December 17, 2024. The bill is currently classified as failed or expired, indicating it did not advance to become law during the 118th Congress.
This bill sought to address the cost of medicines for seniors but did not progress beyond early committee consideration and ultimately expired without enactment.
- The bill targets lower-cost access to prescription medicines specifically for senior citizens.
- It was introduced in the House of Representatives during the 118th Congress.
- The latest recorded action was referral to the Subcommittee on Health, with no further legislative progress.
['Senior citizens who require prescription medications', 'Healthcare providers serving seniors', 'Potentially government health programs that support senior health']
['Lack of available full bill text limits assessment of specific implementation mechanisms and cost implications.', 'No information on funding sources or enforcement provisions is available.', 'Without detailed provisions, oversight and authority structures cannot be evaluated.']
The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health. It did not advance beyond this stage and is classified as failed or expired. The focus on lowering medicine costs for seniors aligns with ongoing legislative interest in healthcare affordability, but no further legislative activity was recorded.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['If enacted, the bill could influence pharmaceutical pricing strategies affecting the broader healthcare market.', 'Potential reduction in out-of-pocket costs for seniors might impact government healthcare spending patterns.', 'Improved access to medicines could affect health outcomes and demand for related healthcare services.']
Transparency is limited due to the absence of the full bill text and official summary, which are critical for thorough analysis. The bill's failure to progress beyond subcommittee referral suggests limited legislative momentum. Oversight and implementation details remain unclear, highlighting the importance of access to complete legislative documentation for public accountability.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.